Brokerages forecast that Vitamin Shoppe, Inc (NYSE:VSI) will announce earnings of $0.39 per share for the current quarter, according to Zacks. Three analysts have issued estimates for Vitamin Shoppe’s earnings. The lowest EPS estimate is $0.34 and the highest is $0.48. Vitamin Shoppe posted earnings per share of $0.55 during the same quarter last year, which suggests a negative year over year growth rate of 29.1%. The business is expected to report its next quarterly earnings report before the market opens on Wednesday, August 9th.
According to Zacks, analysts expect that Vitamin Shoppe will report full year earnings of $1.56 per share for the current financial year, with EPS estimates ranging from $1.50 to $1.63. For the next year, analysts expect that the company will post earnings of $1.62 per share, with EPS estimates ranging from $1.51 to $1.70. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that follow Vitamin Shoppe.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The business had revenue of $316.90 million for the quarter, compared to analysts’ expectations of $325.71 million. During the same period in the previous year, the company earned $0.67 EPS. Vitamin Shoppe’s quarterly revenue was down 5.9% compared to the same quarter last year.
VSI has been the subject of several analyst reports. Barclays PLC reissued an “equal weight” rating and issued a $13.00 target price (down previously from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Morgan Stanley raised shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 target price for the company in a research note on Thursday, May 11th. Zacks Investment Research raised shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. ValuEngine downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Gabelli downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the stock. Vitamin Shoppe has an average rating of “Hold” and an average price target of $24.00.
Hedge funds have recently bought and sold shares of the stock. Arizona State Retirement System boosted its stake in Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares during the period. Texas Permanent School Fund boosted its stake in Vitamin Shoppe by 0.8% in the second quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock valued at $203,000 after buying an additional 145 shares during the period. Mason Street Advisors LLC boosted its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares during the period. Capstone Asset Management Co. boosted its stake in Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares during the period. Finally, Thrivent Financial For Lutherans boosted its stake in Vitamin Shoppe by 1.5% in the first quarter. Thrivent Financial For Lutherans now owns 37,070 shares of the specialty retailer’s stock valued at $747,000 after buying an additional 560 shares during the period.
WARNING: This report was reported by Rincon Hill News and is the sole property of of Rincon Hill News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://rinconhillneighbors.org/2017/08/19/0-39-earnings-per-share-expected-for-vitamin-shoppe-inc-nysevsi-this-quarter-updated-updated.html.
Vitamin Shoppe (NYSE VSI) traded down 3.64% during midday trading on Thursday, hitting $10.60. 287,829 shares of the stock were exchanged. The firm has a 50-day moving average price of $11.10 and a 200-day moving average price of $16.67. Vitamin Shoppe has a one year low of $9.80 and a one year high of $29.39. The stock has a market cap of $252.77 million, a P/E ratio of 13.25 and a beta of 0.69.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with our FREE daily email newsletter.